CHLORPROMAZINE HYDROCHLORIDE

CHLORPROMAZINE HYDROCHLORIDE was reported 953 times

CHLORPROMAZINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 JAPAN COMA SCALE ABNORMAL 1 0.1250
1 NEUTROPENIA NEONATAL 15 0.0670
2 PSEUDOHALLUCINATION 2 0.0645
3 MEDIASTINAL CYST 1 0.0556
4 CEREBRAL MALARIA 1 0.0400
5 SCHIZOPHRENIA, CATATONIC TYPE 1 0.0385
6 MALIGNANT GASTROINTESTINAL OBSTRUCTION 3 0.0357
7 CORNEAL PIGMENTATION 2 0.0351
8 CARDIOVASCULAR DECONDITIONING 2 0.0345
9 SPASMODIC DYSPHONIA 10 0.0330
10 GASTROSTOMY FAILURE 1 0.0323
11 FOETAL DISORDER 24 0.0287
12 PNEUMATOSIS CYSTOIDES INTESTINALIS 1 0.0286
13 POLYSEROSITIS 11 0.0258
14 GLIOSIS 11 0.0256
15 FUNGAL RASH 1 0.0238
16 CATARACT TRAUMATIC 1 0.0233
17 TONGUE THRUST 2 0.0222
18 OVARIAN FAILURE 11 0.0206
19 BEREAVEMENT REACTION 1 0.0169
20 SOCIAL ANXIETY DISORDER 11 0.0167
21 HALLUCINATION, TACTILE 10 0.0150
22 NEGATIVE SYMPTOMS IN SCHIZOPHRENIA 1 0.0149
23 PROCTECTOMY 4 0.0145
24 POUCHITIS 11 0.0128
25 DRUG THERAPY CHANGED 1 0.0120
26 PREMATURE MENOPAUSE 11 0.0119
27 EUTHYROID SICK SYNDROME 1 0.0118
28 PRIMARY EFFUSION LYMPHOMA 1 0.0116
29 MALIGNANT CATATONIA 3 0.0114
30 GRANDIOSITY 4 0.0109
31 AMINO ACID LEVEL ABNORMAL 1 0.0103
32 SOMATIC SYMPTOM DISORDER 11 0.0102
33 MASTOID DISORDER 1 0.0101
34 DEFICIENCY OF BILE SECRETION 1 0.0100
35 PSEUDOCHOLELITHIASIS 1 0.0093
36 REGURGITATION OF FOOD 1 0.0091
37 PLACENTA PRAEVIA HAEMORRHAGE 1 0.0091
38 MYOTONIA 2 0.0090
39 NORMAL TENSION GLAUCOMA 1 0.0086
40 EXTERNAL EAR PAIN 1 0.0085
41 ADMINISTRATION SITE DISCOLOURATION 1 0.0080
42 GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0077
43 CHEMICAL BURN OF GASTROINTESTINAL TRACT 1 0.0073
44 SCHIZOAFFECTIVE DISORDER 13 0.0073
45 DELUSION OF REFERENCE 1 0.0072
46 INSULIN C-PEPTIDE INCREASED 1 0.0072
47 ANDROGENETIC ALOPECIA 2 0.0070
48 ANTIPHOSPHOLIPID SYNDROME 11 0.0068
49 LIMB FRACTURE 1 0.0067
50 MEDICAL DEVICE SITE JOINT INFECTION 1 0.0064
51 PERSECUTORY DELUSION 16 0.0064
52 PROSOPAGNOSIA 1 0.0063
53 MUTISM 9 0.0062
54 CENTRAL HYPOTHYROIDISM 2 0.0060
55 RESPIRATORY TRACT INFECTION BACTERIAL 3 0.0060
56 ILEOSTOMY CLOSURE 2 0.0060
57 DYSDIADOCHOKINESIS 1 0.0058
58 CHEMOTHERAPEUTIC DRUG LEVEL INCREASED 1 0.0056
59 PICA 1 0.0056
60 MACROSOMIA 1 0.0055
61 PRODUCT APPEARANCE CONFUSION 5 0.0054
62 OCULAR PROCEDURAL COMPLICATION 1 0.0052
63 BLOOD GROWTH HORMONE DECREASED 1 0.0050
64 VENOUS THROMBOSIS LIMB 10 0.0048
65 CONGENITAL NYSTAGMUS 1 0.0047
66 LENTICULAR OPACITIES 2 0.0046
67 SEXUALLY INAPPROPRIATE BEHAVIOUR 2 0.0043
68 ILLUSION 7 0.0042
69 POSTOPERATIVE INFECTION 2 0.0042
70 PERIPHERAL VEIN THROMBOSIS 1 0.0042
71 CARDIAC FAILURE HIGH OUTPUT 1 0.0041
72 ALCOHOL ABUSE 11 0.0041
73 PULMONARY VALVE INCOMPETENCE 6 0.0041
74 ELECTROCARDIOGRAM P WAVE ABNORMAL 1 0.0041
75 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 2 0.0040
76 WRONG PATIENT 2 0.0040
77 CYTOMEGALOVIRUS GASTRITIS 1 0.0040
78 WATER INTOXICATION 2 0.0040
79 POSTPARTUM DEPRESSION 1 0.0039
80 ANOSOGNOSIA 3 0.0039
81 CULTURE WOUND POSITIVE 1 0.0038
82 CONVULSION NEONATAL 2 0.0038
83 CORYNEBACTERIUM INFECTION 2 0.0037
84 DYSPRAXIA 2 0.0035
85 PERIORBITAL CONTUSION 1 0.0034
86 INDUCED LABOUR 2 0.0034
87 PUPILLARY LIGHT REFLEX TESTS ABNORMAL 1 0.0032
88 NEUROLEPTIC MALIGNANT SYNDROME 37 0.0031
89 INTESTINAL ANASTOMOSIS 2 0.0031
90 PACKAGING DESIGN ISSUE 1 0.0030
91 LOW BIRTH WEIGHT BABY 24 0.0030
92 DRUG EFFECT FASTER THAN EXPECTED 1 0.0030
93 ACQUIRED HAEMOPHILIA 3 0.0030
94 CHOLURIA 1 0.0029
95 PROTHROMBIN LEVEL INCREASED 1 0.0029
96 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 2 0.0029
97 LORDOSIS 1 0.0028
98 ANTIPSYCHOTIC DRUG LEVEL INCREASED 8 0.0028
99 LYMPHOID TISSUE HYPERPLASIA 1 0.0028
100 CYTOMEGALOVIRUS OESOPHAGITIS 1 0.0027
101 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 3 0.0027
102 AXILLARY VEIN THROMBOSIS 1 0.0027
103 PSYCHOMOTOR SKILLS IMPAIRED 7 0.0027
104 PULMONARY ARTERY THROMBOSIS 2 0.0026
105 DIVERTICULITIS INTESTINAL HAEMORRHAGIC 1 0.0026
106 HYPEREMESIS GRAVIDARUM 1 0.0026
107 MACROCEPHALY 1 0.0026
108 HYPOGLYCAEMIC ENCEPHALOPATHY 1 0.0026
109 PLACENTA PRAEVIA 2 0.0025
110 CARDIAC TAMPONADE 12 0.0025
111 MASKED FACIES 1 0.0025
112 MYOCARDITIS 27 0.0024
113 FEELINGS OF WORTHLESSNESS 3 0.0023
114 INTESTINAL PSEUDO-OBSTRUCTION 2 0.0023
115 CONGENITAL MUSCULOSKELETAL ANOMALY 1 0.0023
116 INTRACRANIAL PRESSURE INCREASED 12 0.0022
117 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 1 0.0021
118 BLOOD BICARBONATE INCREASED 1 0.0021
119 LACTATION DISORDER 1 0.0021
120 BLOOD CORTICOTROPHIN DECREASED 1 0.0020
121 NORMAL NEWBORN 11 0.0020
122 HYPERTHERMIA MALIGNANT 3 0.0020
123 AUTONOMIC NEUROPATHY 2 0.0020
124 CEREBRAL ISCHAEMIA 10 0.0019
125 VIOLENCE-RELATED SYMPTOM 3 0.0019
126 HYPOSPADIAS 4 0.0019
127 FEEDING DISORDER NEONATAL 2 0.0019
128 ANTICHOLINERGIC SYNDROME 3 0.0019
129 MYOGLOBINURIA 1 0.0019
130 EXOMPHALOS 1 0.0019
131 TROPONIN INCREASED 14 0.0018
132 GASTRIC DILATATION 3 0.0018
133 LUNG INFECTION PSEUDOMONAL 1 0.0018
134 APNOEIC ATTACK 1 0.0018
135 BURNING MOUTH SYNDROME 1 0.0018
136 HEAD BANGING 1 0.0018
137 DELUSION 27 0.0017
138 PROTRUSION TONGUE 1 0.0017
139 CATATONIA 9 0.0017
140 BRADYPHRENIA 11 0.0017
141 CONGESTIVE CARDIOMYOPATHY 7 0.0017
142 HALLUCINATIONS, MIXED 7 0.0017
143 BEHAVIOUR DISORDER 9 0.0017
144 PROTHROMBIN TIME RATIO DECREASED 1 0.0016
145 ILEOSTOMY 4 0.0016
146 CYANOSIS NEONATAL 1 0.0016
147 RESTING TREMOR 1 0.0015
148 PERSONALITY DISORDER 4 0.0015
149 SCHIZOPHRENIA 18 0.0015
150 PRE-ECLAMPSIA 7 0.0015
151 CALCULUS BLADDER 2 0.0015
152 HYPERURICAEMIA 6 0.0015
153 HEAD TITUBATION 2 0.0015
154 PSYCHOTIC SYMPTOM 3 0.0015
155 LEIOMYOMA 1 0.0014
156 RENAL APLASIA 1 0.0014
157 ELECTROCARDIOGRAM ST-T CHANGE 1 0.0014
158 NEONATAL ASPHYXIA 1 0.0014
159 WRONG PATIENT RECEIVED PRODUCT 4 0.0014
160 DIET REFUSAL 1 0.0014
161 CORNEAL DEPOSITS 1 0.0013
162 CHOLANGITIS ACUTE 1 0.0013
163 MICROALBUMINURIA 1 0.0013
164 MYOCLONIC EPILEPSY 2 0.0013
165 DIAPHRAGMATIC DISORDER 1 0.0013
166 ASPIRATION PLEURAL CAVITY 1 0.0013
167 BRAIN INJURY 13 0.0013
168 GRIMACING 1 0.0013
169 FOETAL GROWTH RETARDATION 1 0.0013
170 TRANSCRIPTION MEDICATION ERROR 2 0.0013
171 RESPIRATORY ACIDOSIS 5 0.0013
172 BRONCHIAL CARCINOMA 1 0.0013
173 BLOOD FIBRINOGEN INCREASED 1 0.0013
174 NEONATAL DISORDER 2 0.0013
175 INAPPROPRIATE AFFECT 2 0.0013
176 LYMPHOCYTE STIMULATION TEST POSITIVE 1 0.0012
177 DIABETES INSIPIDUS 3 0.0012
178 LUPUS-LIKE SYNDROME 11 0.0012
179 HALLUCINATION, AUDITORY 19 0.0012
180 HOSTILITY 3 0.0012
181 PSEUDOMONAL BACTERAEMIA 1 0.0012
182 ATONIC SEIZURES 1 0.0012
183 BLOOD PROLACTIN ABNORMAL 1 0.0012
184 BLOOD CHLORIDE INCREASED 2 0.0012
185 FOOD REFUSAL 1 0.0011
186 ENTEROCUTANEOUS FISTULA 1 0.0011
187 NEONATAL RESPIRATORY DISTRESS SYNDROME 4 0.0011
188 PRURIGO 1 0.0011
189 ABULIA 1 0.0011
190 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
191 LIVE BIRTH 9 0.0011
192 HUMAN HERPESVIRUS 6 INFECTION 2 0.0011
193 SOPOR 14 0.0011
194 ANTINUCLEAR ANTIBODY INCREASED 1 0.0010
195 PCO2 DECREASED 1 0.0010
196 BONE MARROW DEPRESSION 1 0.0010
197 BRAIN HYPOXIA 1 0.0010
198 INTENTIONAL SELF-INJURY 20 0.0010
199 HYPOTHERMIA 10 0.0010
200 SELF INJURIOUS BEHAVIOUR 3 0.0010
201 BRAIN STEM INFARCTION 1 0.0010
202 ALVEOLITIS ALLERGIC 1 0.0010
203 FOETAL DEATH 5 0.0010
204 PERTUSSIS 1 0.0010
205 COGWHEEL RIGIDITY 1 0.0010
206 DILATATION VENTRICULAR 2 0.0010
207 PSYCHOTIC DISORDER 28 0.0009
208 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 1 0.0009
209 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
210 BLADDER DILATATION 1 0.0009
211 PRODUCT NAME CONFUSION 1 0.0009
212 DRUG EXPOSURE VIA BREAST MILK 1 0.0009
213 SALIVARY HYPERSECRETION 9 0.0009
214 PREMATURE BABY 27 0.0009
215 IMMUNE-MEDIATED HYPOTHYROIDISM 1 0.0009
216 TRICUSPID VALVE INCOMPETENCE 7 0.0009
217 CORTISOL DECREASED 1 0.0009
218 PRIAPISM 3 0.0009
219 CEREBRAL VENTRICLE DILATATION 1 0.0009
220 REACTION TO EXCIPIENT 2 0.0009
221 FLAT AFFECT 2 0.0009
222 DILATATION ATRIAL 1 0.0009
223 BILIRUBIN CONJUGATED INCREASED 2 0.0009
224 BONE MARROW TOXICITY 1 0.0008
225 FIBRIN D DIMER INCREASED 3 0.0008
226 CLOSTRIDIUM COLITIS 1 0.0008
227 PRODUCT PACKAGING CONFUSION 2 0.0008
228 PARKINSONISM 8 0.0008
229 POST-ACUTE COVID-19 SYNDROME 1 0.0008
230 ORTHOSTATIC HYPOTENSION 14 0.0008
231 NEUTROPHIL PERCENTAGE INCREASED 1 0.0008
232 APPENDICITIS PERFORATED 2 0.0008
233 POSTOPERATIVE WOUND COMPLICATION 1 0.0008
234 LIP HAEMORRHAGE 1 0.0008
235 ANGLE CLOSURE GLAUCOMA 2 0.0008
236 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
237 MICROCEPHALY 1 0.0008
238 PLATELET TRANSFUSION 1 0.0008
239 SINUS TACHYCARDIA 11 0.0008
240 LIBIDO DISORDER 1 0.0008
241 DRUG CLEARANCE DECREASED 1 0.0008
242 ENCEPHALITIS AUTOIMMUNE 1 0.0008
243 BLOOD LACTIC ACID INCREASED 4 0.0008
244 PACKED RED BLOOD CELL TRANSFUSION 1 0.0008
245 OESOPHAGEAL CANDIDIASIS 3 0.0008
246 HIRSUTISM 1 0.0008
247 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
248 BLOOD SODIUM INCREASED 2 0.0007
249 DRUG RESISTANCE 19 0.0007
250 PHOTOSENSITIVITY REACTION 12 0.0007
251 JOINT INSTABILITY 1 0.0007
252 H1N1 INFLUENZA 1 0.0007
253 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
254 PSYCHOMOTOR RETARDATION 2 0.0007
255 HEPATIC CYTOLYSIS 9 0.0007
256 MENINGITIS BACTERIAL 1 0.0007
257 CAESAREAN SECTION 8 0.0007
258 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
259 ACUTE ABDOMEN 1 0.0007
260 PSYCHIATRIC SYMPTOM 5 0.0007
261 EXCESSIVE EYE BLINKING 1 0.0007
262 MYASTHENIA GRAVIS CRISIS 1 0.0007
263 HEPATITIS FULMINANT 2 0.0007
264 ISCHAEMIC STROKE 12 0.0007
265 ILEUS PARALYTIC 3 0.0007
266 MANIA 11 0.0007
267 RESPIRATORY DEPRESSION 8 0.0007
268 ORAL MUCOSAL ERUPTION 1 0.0007
269 DAYDREAMING 1 0.0006
270 POLYCYSTIC OVARIES 1 0.0006
271 TALIPES 2 0.0006
272 FEELING OF DESPAIR 3 0.0006
273 HYPOTONIA NEONATAL 1 0.0006
274 ELECTROCARDIOGRAM QT PROLONGED 23 0.0006
275 PARANOIA 11 0.0006
276 SINUS ARREST 1 0.0006
277 MEGACOLON 1 0.0006
278 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
279 GESTATIONAL DIABETES 3 0.0006
280 LIMB DEFORMITY 1 0.0006
281 PREMATURE DELIVERY 10 0.0006
282 STUPOR 2 0.0006
283 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0006
284 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
285 HICCUPS 5 0.0006
286 METABOLIC SYNDROME 1 0.0006
287 DRUG WITHDRAWAL SYNDROME NEONATAL 9 0.0006
288 SEBORRHOEIC DERMATITIS 1 0.0006
289 MULTIPLE DRUG OVERDOSE 3 0.0006
290 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
291 EXPOSURE TO SARS-COV-2 1 0.0006
292 GAZE PALSY 1 0.0006
293 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
294 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
295 PERITONITIS 12 0.0006
296 CARDIAC MURMUR 5 0.0006
297 HYPOPITUITARISM 1 0.0006
298 CEREBRAL INFARCTION 14 0.0006
299 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
300 EXTRAPYRAMIDAL DISORDER 14 0.0006
301 TOXICITY TO VARIOUS AGENTS 95 0.0006
302 GLOSSITIS 2 0.0006
303 PNEUMONIA ASPIRATION 14 0.0006
304 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
305 INTESTINAL ISCHAEMIA 3 0.0005
306 PSYCHOMOTOR HYPERACTIVITY 9 0.0005
307 NASAL OBSTRUCTION 1 0.0005
308 STATUS EPILEPTICUS 6 0.0005
309 MITRAL VALVE INCOMPETENCE 6 0.0005
310 SNORING 2 0.0005
311 BONE MARROW TRANSPLANT 1 0.0005
312 POISONING DELIBERATE 5 0.0005
313 HYPOPROTEINAEMIA 1 0.0005
314 GRANULOCYTOPENIA 3 0.0005
315 MATERNAL DRUGS AFFECTING FOETUS 4 0.0005
316 HALLUCINATION, VISUAL 11 0.0005
317 CLEFT PALATE 1 0.0005
318 CONVERSION DISORDER 1 0.0005
319 AKATHISIA 7 0.0005
320 IMMUNE-MEDIATED HEPATIC DISORDER 1 0.0005
321 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 1 0.0005
322 POLYDIPSIA 2 0.0005
323 ATAXIA 6 0.0005
324 PLEURISY 3 0.0005
325 HYPOGLYCAEMIC UNCONSCIOUSNESS 1 0.0005
326 RHABDOMYOLYSIS 21 0.0005
327 CARDIO-RESPIRATORY ARREST 21 0.0005
328 SEDATION 13 0.0005
329 CHANGE OF BOWEL HABIT 1 0.0005
330 CHOLANGITIS SCLEROSING 1 0.0005
331 AKINESIA 1 0.0005
332 HYPOKINESIA 7 0.0005
333 PHYSICAL ASSAULT 1 0.0005
334 SELF-INJURIOUS IDEATION 2 0.0005
335 NEUROGENIC BLADDER 1 0.0005
336 HYPERPYREXIA 2 0.0005
337 TONGUE DISCOMFORT 2 0.0005
338 ANAEMIA MACROCYTIC 1 0.0005
339 OCULOGYRIC CRISIS 1 0.0005
340 DEREALISATION 1 0.0005
341 HYPERPROLACTINAEMIA 3 0.0005
342 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
343 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
344 ADENOCARCINOMA 1 0.0004
345 CORNEAL OEDEMA 1 0.0004
346 DRUG-INDUCED LIVER INJURY 14 0.0004
347 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
348 COLITIS ISCHAEMIC 3 0.0004
349 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
350 HEPATOCELLULAR DAMAGE 1 0.0004
351 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
352 AGGRESSION 22 0.0004
353 EYE MOVEMENT DISORDER 3 0.0004
354 PANCREATITIS NECROTISING 1 0.0004
355 DRUG ABUSE 36 0.0004
356 AGRANULOCYTOSIS 8 0.0004
357 COGNITIVE DISORDER 20 0.0004
358 TARDIVE DYSKINESIA 12 0.0004
359 PRURITUS GENITAL 1 0.0004
360 PANCREATITIS CHRONIC 1 0.0004
361 MUSCLE RIGIDITY 5 0.0004
362 FAECAL INCONTINENCE 2 0.0004
363 AFFECT LABILITY 4 0.0004
364 ENTEROCOCCAL INFECTION 2 0.0004
365 DERMAL CYST 1 0.0004
366 FREQUENT BOWEL MOVEMENTS 11 0.0004
367 ACUTE PSYCHOSIS 1 0.0004
368 DEVICE INFUSION ISSUE 1 0.0004
369 HYPERNATRAEMIA 2 0.0004
370 CATHETER SITE HAEMORRHAGE 1 0.0004
371 PHYSICAL DECONDITIONING 1 0.0004
372 TRISMUS 2 0.0004
373 LIPOMA 1 0.0004
374 COMPARTMENT SYNDROME 1 0.0004
375 MULTIPLE ALLERGIES 3 0.0004
376 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
377 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
378 AFFECTIVE DISORDER 3 0.0004
379 MATERNAL EXPOSURE DURING PREGNANCY 34 0.0004
380 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
381 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
382 ASCITES 11 0.0004
383 FOETAL EXPOSURE DURING PREGNANCY 30 0.0004
384 CLONUS 1 0.0004
385 FAECALOMA 2 0.0004
386 RHEUMATOID NODULE 1 0.0004
387 DRUG SCREEN FALSE POSITIVE 1 0.0004
388 CHOLECYSTITIS INFECTIVE 1 0.0004
389 CHOKING 7 0.0004
390 HAEMODIALYSIS 3 0.0004
391 ENDOTRACHEAL INTUBATION 1 0.0004
392 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
393 RENAL TUBULAR DISORDER 1 0.0004
394 COLECTOMY 2 0.0004
395 NEUTROPHIL COUNT ABNORMAL 1 0.0004
396 EJACULATION DISORDER 1 0.0004
397 OXYGEN SATURATION ABNORMAL 1 0.0004
398 ENTEROCOLITIS 2 0.0003
399 SUICIDE ATTEMPT 21 0.0003
400 ESCHERICHIA SEPSIS 1 0.0003
401 PRODUCT LABEL CONFUSION 2 0.0003
402 ABORTION 1 0.0003
403 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
404 COMA 16 0.0003
405 BRAIN HERNIATION 1 0.0003
406 JAUNDICE 9 0.0003
407 METABOLIC ENCEPHALOPATHY 1 0.0003
408 MIXED LIVER INJURY 1 0.0003
409 HEPATITIS CHOLESTATIC 2 0.0003
410 LOSS OF EMPLOYMENT 1 0.0003
411 CONTRAINDICATED PRODUCT ADMINISTERED 10 0.0003
412 FOETAL GROWTH RESTRICTION 2 0.0003
413 ACCIDENTAL OVERDOSE 12 0.0003
414 DYSCHEZIA 1 0.0003
415 INTENTIONAL OVERDOSE 21 0.0003
416 DIABETIC FOOT 1 0.0003
417 MASTICATION DISORDER 1 0.0003
418 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
419 BRAIN DEATH 1 0.0003
420 OLIGURIA 2 0.0003
421 EJECTION FRACTION DECREASED 5 0.0003
422 MENTAL DISORDER 14 0.0003
423 RESPIRATORY RATE DECREASED 1 0.0003
424 INFUSION SITE PRURITUS 1 0.0003
425 DELIRIUM 11 0.0003
426 PNEUMOTHORAX 5 0.0003
427 MULTIPLE DRUG OVERDOSE INTENTIONAL 1 0.0003
428 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
429 POSTURE ABNORMAL 1 0.0003
430 CEREBRAL HAEMORRHAGE 11 0.0003
431 LYMPHOCYTE COUNT INCREASED 1 0.0003
432 HYPOGAMMAGLOBULINAEMIA 2 0.0003
433 TACHYCARDIA 27 0.0003
434 EXPOSURE DURING BREAST FEEDING 1 0.0003
435 HYPOTONIA 3 0.0003
436 OLIGOHYDRAMNIOS 1 0.0003
437 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
438 POTENTIATING DRUG INTERACTION 1 0.0003
439 WRONG PRODUCT ADMINISTERED 2 0.0003
440 NEUTROPHIL COUNT INCREASED 3 0.0003
441 INITIAL INSOMNIA 3 0.0003
442 BRONCHOPNEUMONIA 1 0.0003
443 HEPATIC FIBROSIS 1 0.0003
444 MULTI-ORGAN FAILURE 5 0.0003
445 MENTAL IMPAIRMENT 7 0.0003
446 HYPERREFLEXIA 1 0.0003
447 HANGOVER 1 0.0003
448 DEPRESSIVE SYMPTOM 1 0.0003
449 JAUNDICE CHOLESTATIC 1 0.0003
450 FACIAL PARESIS 1 0.0003
451 DRUG ERUPTION 5 0.0003
452 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
453 NEUTROPENIC SEPSIS 2 0.0003
454 COMPLETED SUICIDE 23 0.0003
455 HYPOPHAGIA 7 0.0003
456 BLOOD PHOSPHORUS DECREASED 1 0.0003
457 EXPOSURE DURING PREGNANCY 17 0.0003
458 NEURODERMATITIS 1 0.0003
459 MALNUTRITION 3 0.0003
460 GENERAL SYMPTOM 2 0.0003
461 PROTEIN TOTAL DECREASED 1 0.0003
462 HEPATIC NECROSIS 1 0.0003
463 HYPOCALCAEMIA 5 0.0003
464 MYOCARDIAL ISCHAEMIA 3 0.0003
465 HYPERTHERMIA 2 0.0003
466 WITHDRAWAL SYNDROME 11 0.0003
467 SEROTONIN SYNDROME 5 0.0003
468 DYSTONIA 5 0.0003
469 TREATMENT NONCOMPLIANCE 14 0.0003
470 HYPOXIA 9 0.0003
471 BLOOD ALBUMIN DECREASED 2 0.0003
472 PREGNANCY 5 0.0002
473 CANDIDIASIS 1 0.0002
474 CYSTITIS HAEMORRHAGIC 1 0.0002
475 ENURESIS 1 0.0002
476 HOMICIDAL IDEATION 1 0.0002
477 PLEURAL EFFUSION 15 0.0002
478 COLITIS ULCERATIVE 11 0.0002
479 ENCEPHALOPATHY 6 0.0002
480 HYPERAESTHESIA 2 0.0002
481 HEPATIC FUNCTION ABNORMAL 9 0.0002
482 SUICIDAL IDEATION 22 0.0002
483 EOSINOPHIL COUNT INCREASED 2 0.0002
484 URINARY RETENTION 8 0.0002
485 BLOOD UREA INCREASED 4 0.0002
486 BRAIN OEDEMA 3 0.0002
487 INFUSION SITE ERYTHEMA 2 0.0002
488 OVERDOSE 51 0.0002
489 URINARY INCONTINENCE 7 0.0002
490 RENAL FAILURE ACUTE 10 0.0002
491 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
492 MYDRIASIS 3 0.0002
493 UNRESPONSIVE TO STIMULI 6 0.0002
494 HORDEOLUM 1 0.0002
495 PYELONEPHRITIS 2 0.0002
496 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
497 TREATMENT FAILURE 19 0.0002
498 URINE OUTPUT DECREASED 2 0.0002
499 DYSPHEMIA 1 0.0002
500 DRUG INTERACTION 36 0.0002
501 HYPOGLYCAEMIA 11 0.0002
502 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
503 ABDOMINAL ABSCESS 1 0.0002
504 BLOOD CREATINE INCREASED 1 0.0002
505 HALLUCINATION 17 0.0002
506 DEVELOPMENTAL DELAY 2 0.0002
507 RESTLESSNESS 8 0.0002
508 AGITATION 16 0.0002
509 IRON DEFICIENCY ANAEMIA 2 0.0002
510 PERSONALITY CHANGE 2 0.0002
511 PERFORMANCE STATUS DECREASED 1 0.0002
512 NEPHROPATHY 2 0.0002
513 NEUTROPENIA 29 0.0002
514 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
515 BLOOD PROLACTIN INCREASED 1 0.0002
516 RED BLOOD CELL COUNT DECREASED 6 0.0002
517 EYE INFLAMMATION 2 0.0002
518 MEDICATION RESIDUE PRESENT 1 0.0002
519 CARDIOGENIC SHOCK 3 0.0002
520 NON-SMALL CELL LUNG CANCER 1 0.0002
521 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
522 ANGER 7 0.0002
523 SINUS BRADYCARDIA 2 0.0002
524 DIZZINESS POSTURAL 2 0.0002
525 RESPIRATORY FAILURE 15 0.0002
526 HEPATOMEGALY 2 0.0002
527 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
528 INFLAMMATORY MARKER INCREASED 1 0.0002
529 HAEMATOCRIT DECREASED 4 0.0002
530 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
531 HYPERAMMONAEMIA 1 0.0002
532 DERMATITIS EXFOLIATIVE 1 0.0002
533 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
534 SLUGGISHNESS 2 0.0002
535 FEMORAL NECK FRACTURE 1 0.0002
536 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
537 CACHEXIA 1 0.0002
538 GYNAECOMASTIA 6 0.0002
539 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
540 C-REACTIVE PROTEIN INCREASED 7 0.0002
541 WEIGHT FLUCTUATION 2 0.0002
542 POLYARTHRITIS 1 0.0002
543 SUDDEN DEATH 2 0.0002
544 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
545 LEARNING DISABILITY 1 0.0002
546 ANAL ABSCESS 1 0.0002
547 BLOOD BILIRUBIN INCREASED 5 0.0002
548 BLOOD POTASSIUM INCREASED 3 0.0002
549 BIPOLAR DISORDER 2 0.0002
550 ASPIRATION 2 0.0002
551 AUTISM SPECTRUM DISORDER 1 0.0002
552 PROSTATIC DISORDER 1 0.0002
553 SOMNOLENCE 36 0.0002
554 INTESTINAL PERFORATION 2 0.0002
555 ABNORMAL BEHAVIOUR 7 0.0002
556 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
557 CHOLECYSTITIS ACUTE 1 0.0002
558 NEUROLOGICAL SYMPTOM 1 0.0002
559 SHOCK 4 0.0002
560 BLOOD URIC ACID INCREASED 1 0.0002
561 ELECTROLYTE IMBALANCE 2 0.0002
562 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
563 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
564 MYOCLONUS 2 0.0002
565 ODYNOPHAGIA 1 0.0002
566 DIABETIC KETOACIDOSIS 4 0.0002
567 ADRENAL INSUFFICIENCY 2 0.0002
568 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
569 DRUG ABUSER 1 0.0002
570 MENISCUS INJURY 1 0.0002
571 CARDIOMEGALY 2 0.0002
572 PIGMENTATION DISORDER 1 0.0002
573 DRUG DIVERSION 1 0.0002
574 MEDICATION ERROR 9 0.0002
575 MIDDLE INSOMNIA 3 0.0002
576 POISONING 2 0.0002
577 INTESTINAL OBSTRUCTION 6 0.0002
578 BLOOD SODIUM DECREASED 3 0.0002
579 BLEPHAROSPASM 1 0.0002
580 LIVER DISORDER 7 0.0002
581 FEELING JITTERY 3 0.0002
582 CONVULSION 9 0.0002
583 INCREASED APPETITE 3 0.0002
584 METABOLIC ACIDOSIS 5 0.0002
585 GALACTORRHOEA 1 0.0002
586 PROCTALGIA 1 0.0002
587 CARDIAC FLUTTER 1 0.0002
588 NODULE 2 0.0002
589 ARTHRITIS 12 0.0002
590 PULMONARY CONGESTION 2 0.0002
591 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
592 ADVERSE REACTION 2 0.0002
593 VISUAL ACUITY REDUCED 5 0.0002
594 CARDIAC FAILURE ACUTE 1 0.0001
595 MENINGITIS 1 0.0001
596 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
597 DROOLING 1 0.0001
598 AUTOIMMUNE HEPATITIS 1 0.0001
599 INTENTIONAL DRUG MISUSE 3 0.0001
600 RIGHT VENTRICULAR FAILURE 1 0.0001
601 BLOOD TEST ABNORMAL 2 0.0001
602 CONFUSIONAL STATE 23 0.0001
603 PULMONARY TOXICITY 1 0.0001
604 HAND FRACTURE 1 0.0001
605 EATING DISORDER 3 0.0001
606 RETINAL HAEMORRHAGE 1 0.0001
607 METASTASIS 1 0.0001
608 LEUKOPENIA 7 0.0001
609 PARALYSIS 2 0.0001
610 HYPOTENSION 28 0.0001
611 IMPAIRED QUALITY OF LIFE 2 0.0001
612 LIVER FUNCTION TEST ABNORMAL 4 0.0001
613 FAECES SOFT 1 0.0001
614 APATHY 2 0.0001
615 ORAL DISORDER 1 0.0001
616 DYSURIA 5 0.0001
617 BLOOD PRESSURE DECREASED 9 0.0001
618 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
619 CARDIOMYOPATHY 2 0.0001
620 CEREBRAL DISORDER 1 0.0001
621 HEPATOTOXICITY 3 0.0001
622 IMMUNODEFICIENCY 2 0.0001
623 ATRIAL FIBRILLATION 13 0.0001
624 PANCREATITIS ACUTE 3 0.0001
625 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
626 ACIDOSIS 1 0.0001
627 THYROID DISORDER 2 0.0001
628 CONGENITAL ANOMALY 1 0.0001
629 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
630 HYPOALBUMINAEMIA 1 0.0001
631 APNOEA 1 0.0001
632 FURUNCLE 1 0.0001
633 OBESITY 2 0.0001
634 MIOSIS 1 0.0001
635 LACTIC ACIDOSIS 4 0.0001
636 DYSKINESIA 5 0.0001
637 ASPHYXIA 1 0.0001
638 LIVER INJURY 3 0.0001
639 POLYURIA 1 0.0001
640 ACUTE CORONARY SYNDROME 1 0.0001
641 BREAST CANCER STAGE II 1 0.0001
642 PRODUCT CONTAINER ISSUE 1 0.0001
643 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
644 IRRITABILITY 7 0.0001
645 ANURIA 1 0.0001
646 MUSCLE STRAIN 1 0.0001
647 NEUROTOXICITY 2 0.0001
648 EOSINOPHILIA 2 0.0001
649 AMENORRHOEA 2 0.0001
650 IMMUNOSUPPRESSION 1 0.0001
651 PRODUCT COMMUNICATION ISSUE 1 0.0001
652 BRADYCARDIA 6 0.0001
653 RESPIRATORY RATE INCREASED 1 0.0001
654 DEHYDRATION 15 0.0001
655 CARDIOTOXICITY 1 0.0001
656 HYPERGLYCAEMIA 4 0.0001
657 BRAIN NEOPLASM 1 0.0001
658 RESPIRATORY ARREST 3 0.0001
659 HYPOKALAEMIA 5 0.0001
660 GRAND MAL CONVULSION 1 0.0001
661 MENTAL STATUS CHANGES 3 0.0001
662 HEPATIC STEATOSIS 2 0.0001
663 ERYTHEMA MULTIFORME 1 0.0001
664 DYSARTHRIA 4 0.0001
665 ARTERIOSCLEROSIS 1 0.0001
666 ABORTION INDUCED 1 0.0001
667 DEPRESSION 24 0.0001
668 HYPERSOMNIA 3 0.0001
669 PRODUCT SUBSTITUTION ISSUE 6 0.0001
670 CHOLESTASIS 2 0.0001
671 SEIZURE 12 0.0001
672 ATELECTASIS 1 0.0001
673 TREMOR 17 0.0001
674 RENAL TUBULAR NECROSIS 1 0.0001
675 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
676 BODY TEMPERATURE DECREASED 1 0.0001
677 LOSS OF CONSCIOUSNESS 13 0.0001
678 DISORIENTATION 4 0.0001
679 CATARACT 6 0.0001
680 UPPER LIMB FRACTURE 2 0.0001
681 OVARIAN CYST 1 0.0001
682 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
683 SLEEP DISORDER 7 0.0001
684 EMPHYSEMA 1 0.0001
685 PERITONITIS BACTERIAL 1 0.0001
686 THERAPEUTIC RESPONSE DECREASED 6 0.0001
687 DRUG LEVEL DECREASED 1 0.0001
688 MOTOR DYSFUNCTION 1 0.0001
689 EUPHORIC MOOD 1 0.0001
690 TOOTH LOSS 2 0.0001
691 EYE DISCHARGE 1 0.0001
692 NERVOUS SYSTEM DISORDER 3 0.0001
693 PULMONARY HYPERTENSION 2 0.0001
694 SPEECH DISORDER 5 0.0001
695 DEPRESSED MOOD 5 0.0001
696 HYPERHIDROSIS 12 0.0001
697 DECREASED ACTIVITY 1 0.0001
698 PRODUCT DISPENSING ERROR 2 0.0001
699 INTENTIONAL PRODUCT MISUSE 8 0.0001
700 HEART RATE INCREASED 9 0.0001
701 RASH MACULO-PAPULAR 2 0.0001
702 INFECTION 13 0.0001
703 TYPE 2 DIABETES MELLITUS 3 0.0001
704 OCULAR DISCOMFORT 1 0.0001
705 BLOOD CALCIUM DECREASED 1 0.0001
706 HYPONATRAEMIA 5 0.0001
707 REBOUND EFFECT 1 0.0001
708 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
709 IMPAIRED DRIVING ABILITY 1 0.0001
710 CHOLECYSTITIS 1 0.0001
711 ACCIDENT 1 0.0001
712 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
713 CEREBROVASCULAR ACCIDENT 14 0.0001
714 PRESYNCOPE 2 0.0001
715 NO THERAPEUTIC RESPONSE 1 0.0001
716 CYTOPENIA 1 0.0001
717 GENERALISED OEDEMA 1 0.0001
718 PRODUCT USE IN UNAPPROVED INDICATION 20 0.0001
719 SEPSIS 9 0.0001
720 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
721 ILEUS 1 0.0001
722 DERMATITIS ALLERGIC 1 0.0001
723 CELLULITIS 4 0.0001
724 HAEMATEMESIS 2 0.0001
725 CARDIOVASCULAR DISORDER 2 0.0001
726 HEPATITIS 2 0.0001
727 GENITAL HAEMORRHAGE 1 0.0001
728 HIATUS HERNIA 1 0.0001
729 PLATELET COUNT INCREASED 1 0.0001
730 MUCOSAL INFLAMMATION 2 0.0001
731 ANHEDONIA 2 0.0001
732 ORAL CANDIDIASIS 1 0.0001
733 CONDITION AGGRAVATED 23 0.0001
734 DYSMENORRHOEA 1 0.0001
735 JOINT RANGE OF MOTION DECREASED 1 0.0001
736 DYSPHAGIA 7 0.0001
737 NEUTROPHIL COUNT DECREASED 3 0.0001
738 PNEUMONITIS 2 0.0001
739 DRUG TOXICITY 1 0.0001
740 HEPATIC ENZYME INCREASED 5 0.0001
741 ERYTHEMA 15 0.0001
742 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
743 CARDIAC ARREST 6 0.0001
744 HUNGER 1 0.0001
745 ROAD TRAFFIC ACCIDENT 3 0.0001
746 PANCYTOPENIA 4 0.0001
747 SEASONAL ALLERGY 1 0.0001
748 MYALGIA 12 0.0001
749 BALANCE DISORDER 6 0.0001
750 HYPERTHYROIDISM 1 0.0001
751 SEPTIC SHOCK 3 0.0001
752 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
753 GASTROENTERITIS 1 0.0001
754 CHEST DISCOMFORT 7 0.0001
755 GAIT DISTURBANCE 13 0.0001
756 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
757 PULMONARY OEDEMA 3 0.0001
758 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
759 HAEMORRHAGE INTRACRANIAL 1 0.0001
760 BLOOD POTASSIUM DECREASED 2 0.0001
761 LACRIMATION INCREASED 2 0.0001
762 DISCOMFORT 4 0.0001
763 EPILEPSY 2 0.0001
764 INSURANCE ISSUE 1 0.0001
765 OROPHARYNGEAL PAIN 6 0.0001
766 URINARY TRACT INFECTION 11 0.0001
767 INSOMNIA 17 0.0001
768 CYANOSIS 1 0.0001
769 ARRHYTHMIA 3 0.0001
770 PULMONARY EMBOLISM 6 0.0001
771 RESPIRATORY TRACT CONGESTION 1 0.0001
772 HYPOTHYROIDISM 2 0.0001
773 CARDIAC FAILURE 5 0.0001
774 MUSCLE TIGHTNESS 1 0.0001
775 IMPAIRED HEALING 2 0.0001
776 OFF LABEL USE 53 0.0001
777 DRUG LEVEL INCREASED 1 0.0001
778 PERICARDITIS 1 0.0001
779 RENAL IMPAIRMENT 5 0.0001
780 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
781 HEMIPARESIS 1 0.0001
782 ACUTE KIDNEY INJURY 9 0.0001
783 CIRCULATORY COLLAPSE 1 0.0001
784 METRORRHAGIA 1 0.0001
785 HAEMATURIA 2 0.0001
786 MEMORY IMPAIRMENT 8 0.0001
787 MUSCULOSKELETAL DISCOMFORT 1 0.0001
788 NIGHTMARE 2 0.0001
789 ECZEMA 3 0.0001
790 HYPERKALAEMIA 2 0.0001
791 MALAISE 25 0.0001
792 DRUG INEFFECTIVE 75 0.0001
793 INJURY 4 0.0001
794 COLD SWEAT 1 0.0001
795 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
796 LYMPHOCYTE COUNT DECREASED 1 0.0001
797 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
798 HEAD DISCOMFORT 1 0.0001
799 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
800 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
801 PNEUMONIA 18 0.0001
802 MYELOSUPPRESSION 2 0.0001
803 LEUKOCYTOSIS 1 0.0001
804 PYREXIA 19 0.0001
805 PANIC ATTACK 2 0.0001
806 CHEST PAIN 10 0.0001
807 THROMBOCYTOPENIA 6 0.0001
808 BACTERIAL INFECTION 1 0.0001
809 OXYGEN SATURATION DECREASED 3 0.0001
810 FRACTURE 1 0.0001
811 FOOT FRACTURE 1 0.0001
812 GASTRIC ULCER 1 0.0001
813 LETHARGY 3 0.0001
814 DIZZINESS 26 0.0001
815 POST PROCEDURAL COMPLICATION 1 0.0001
816 ACUTE RESPIRATORY FAILURE 1 0.0001
817 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
818 EAR PAIN 1 0.0001
819 COVID-19 9 0.0001
820 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
821 HAEMORRHOIDS 1 0.0001
822 PALPITATIONS 6 0.0001
823 ORAL HERPES 1 0.0001
824 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
825 BLOOD PRESSURE ABNORMAL 1 0.0001
826 PRESCRIBED UNDERDOSE 1 0.0001
827 ABORTION SPONTANEOUS 2 0.0000
828 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
829 FULL BLOOD COUNT DECREASED 1 0.0000
830 PRODUCT ADMINISTRATION ERROR 1 0.0000
831 FEEDING DISORDER 1 0.0000
832 BONE MARROW FAILURE 1 0.0000
833 BLINDNESS 2 0.0000
834 BODY TEMPERATURE INCREASED 1 0.0000
835 HAEMOGLOBIN DECREASED 5 0.0000
836 RIB FRACTURE 1 0.0000
837 HAEMORRHAGE 5 0.0000
838 DERMATITIS 1 0.0000
839 DECREASED APPETITE 11 0.0000
840 PLATELET COUNT DECREASED 5 0.0000
841 IMPAIRED WORK ABILITY 1 0.0000
842 LIVER FUNCTION TEST INCREASED 1 0.0000
843 RECTAL HAEMORRHAGE 2 0.0000
844 DEEP VEIN THROMBOSIS 3 0.0000
845 BLOOD CREATININE INCREASED 3 0.0000
846 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
847 DRUG WITHDRAWAL SYNDROME 4 0.0000
848 FEBRILE NEUTROPENIA 3 0.0000
849 ADVERSE DRUG REACTION 4 0.0000
850 MUSCULAR WEAKNESS 5 0.0000
851 PRODUCT AVAILABILITY ISSUE 1 0.0000
852 SKIN DISCOLOURATION 2 0.0000
853 MUSCLE TWITCHING 1 0.0000
854 PERICARDIAL EFFUSION 1 0.0000
855 HEADACHE 27 0.0000
856 VOMITING 20 0.0000
857 OCULAR HYPERAEMIA 2 0.0000
858 MIGRAINE 4 0.0000
859 RASH ERYTHEMATOUS 2 0.0000
860 MOBILITY DECREASED 3 0.0000
861 BLOOD GLUCOSE DECREASED 2 0.0000
862 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
863 LOCALISED INFECTION 1 0.0000
864 UNEVALUABLE EVENT 3 0.0000
865 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
866 DIABETES MELLITUS 3 0.0000
867 ERECTILE DYSFUNCTION 1 0.0000
868 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
869 INFLAMMATION 2 0.0000
870 NERVOUSNESS 2 0.0000
871 GASTRITIS 1 0.0000
872 HYPERTENSION 8 0.0000
873 DRUG DEPENDENCE 6 0.0000
874 DISTURBANCE IN ATTENTION 2 0.0000
875 DRY MOUTH 3 0.0000
876 RASH PRURITIC 2 0.0000
877 LIMB INJURY 1 0.0000
878 ANAEMIA 7 0.0000
879 CONSTIPATION 8 0.0000
880 PRURITUS 14 0.0000
881 RESPIRATORY DISTRESS 1 0.0000
882 ABNORMAL DREAMS 1 0.0000
883 FATIGUE 28 0.0000
884 FEELING COLD 1 0.0000
885 NECK PAIN 2 0.0000
886 DEMENTIA 1 0.0000
887 PAIN IN JAW 1 0.0000
888 ANXIETY 10 0.0000
889 INTENTIONAL DOSE OMISSION 1 0.0000
890 ANGINA PECTORIS 1 0.0000
891 DYSSTASIA 1 0.0000
892 LABORATORY TEST ABNORMAL 1 0.0000
893 OESOPHAGEAL CARCINOMA 1 0.0000
894 ARTHRALGIA 14 0.0000
895 FEELING ABNORMAL 8 0.0000
896 HEPATIC FAILURE 1 0.0000
897 CORONARY ARTERY DISEASE 1 0.0000
898 STOMATITIS 2 0.0000
899 OEDEMA PERIPHERAL 4 0.0000
900 BLOOD PRESSURE INCREASED 5 0.0000
901 FEELING HOT 2 0.0000
902 HOSPITALISATION 5 0.0000
903 LIMB DISCOMFORT 1 0.0000
904 VISUAL IMPAIRMENT 4 0.0000
905 WEIGHT DECREASED 9 0.0000
906 HEAD INJURY 1 0.0000
907 CYSTITIS 1 0.0000
908 DRUG INTOLERANCE 3 0.0000
909 RHINORRHOEA 2 0.0000
910 CHOLELITHIASIS 1 0.0000
911 OSTEONECROSIS 1 0.0000
912 EYE DISORDER 1 0.0000
913 RENAL FAILURE 4 0.0000
914 FALL 10 0.0000
915 FUNGAL INFECTION 1 0.0000
916 SYNCOPE 3 0.0000
917 PAIN 18 0.0000
918 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
919 HEART RATE DECREASED 1 0.0000
920 LYMPHADENOPATHY 1 0.0000
921 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
922 DIARRHOEA 18 0.0000
923 DRUG EFFECT INCOMPLETE 1 0.0000
924 NASOPHARYNGITIS 5 0.0000
925 HYPOAESTHESIA 4 0.0000
926 ASTHENIA 10 0.0000
927 CHRONIC KIDNEY DISEASE 2 0.0000
928 PERIPHERAL SWELLING 4 0.0000
929 EXTRA DOSE ADMINISTERED 1 0.0000
930 LUNG NEOPLASM MALIGNANT 1 0.0000
931 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
932 URTICARIA 4 0.0000
933 HYPOACUSIS 1 0.0000
934 DEVICE LEAKAGE 1 0.0000
935 MUSCULOSKELETAL STIFFNESS 2 0.0000
936 WEIGHT INCREASED 5 0.0000
937 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
938 ADVERSE EVENT 2 0.0000
939 BACK PAIN 5 0.0000
940 ABDOMINAL PAIN 5 0.0000
941 BLOOD CHOLESTEROL INCREASED 1 0.0000
942 COUGH 6 0.0000
943 BLOOD GLUCOSE INCREASED 4 0.0000
944 NEUROPATHY PERIPHERAL 2 0.0000
945 DISEASE RECURRENCE 1 0.0000
946 RENAL CANCER 1 0.0000
947 PRODUCT DOSE OMISSION ISSUE 6 0.0000
948 PAIN IN EXTREMITY 6 0.0000
949 NAUSEA 16 0.0000
950 FLUSHING 2 0.0000
951 ILLNESS 2 0.0000
952 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
953 ABDOMINAL DISTENSION 2 0.0000
954 MUSCULOSKELETAL PAIN 1 0.0000
955 PANCREATITIS 1 0.0000
956 OEDEMA 1 0.0000
957 ANAPHYLACTIC REACTION 1 0.0000
958 INFLUENZA 2 0.0000
959 EYE PAIN 1 0.0000
960 ASTHMA 2 0.0000
961 INCORRECT DOSE ADMINISTERED 4 0.0000
962 EYE IRRITATION 1 0.0000
963 MYOCARDIAL INFARCTION 3 0.0000
964 DYSPHONIA 1 0.0000
965 NASAL CONGESTION 1 0.0000
966 BLADDER CANCER 1 0.0000
967 EMOTIONAL DISTRESS 2 0.0000
968 MUSCLE SPASMS 3 0.0000
969 DEATH 14 0.0000
970 HYPERSENSITIVITY 3 0.0000
971 PRODUCT DOSE OMISSION 1 0.0000
972 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
973 ABDOMINAL PAIN UPPER 3 0.0000
974 INJECTION SITE REACTION 1 0.0000
975 DEVICE MALFUNCTION 1 0.0000
976 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
977 RASH 6 0.0000
978 EPISTAXIS 1 0.0000
979 ACNE 1 0.0000
980 CARDIAC FAILURE CONGESTIVE 1 0.0000
981 INFLUENZA LIKE ILLNESS 1 0.0000
982 ABDOMINAL DISCOMFORT 2 0.0000
983 CARDIAC DISORDER 1 0.0000
984 PRODUCT USE ISSUE 2 0.0000
985 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
986 SINUSITIS 1 0.0000
987 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
988 RHEUMATOID ARTHRITIS 1 0.0000
989 DISEASE PROGRESSION 1 0.0000
990 JOINT SWELLING 1 0.0000
991 DRY SKIN 1 0.0000
992 DYSPNOEA 4 0.0000
993 INJECTION SITE PAIN 2 0.0000
994 ALOPECIA 1 0.0000